Winston Kung
Director of Finance/CFO at ARRIVENT BIOPHARMA, INC.
Net worth: 153 042 $ as of 2024-05-30
Profile
Winston Kung is the founder of Alliance Management Group.
He currently holds the position of Independent Director at Janux Therapeutics, Inc. since 2022 and Chief Financial Officer & Treasurer at Arrivent BioPharma, Inc. since 2024.
Previously, he worked as Director-Global Healthcare at Citigroup, Inc. from 2010 to 2013, Director at Aitia, Inc., Director at Alliqua BioMedical, Inc. from 2016 to 2017, Principal at Amgen, Inc. from 2004 to 2007, VP-Business Development & Global Alliances at Celgene Corp.
from 2013 to 2017, Vice President-Global Mergers & Acquisitions at Lehman Brothers, Inc. from 2007 to 2010, Chief Operating & Financial Officer at PMV Pharmaceuticals, Inc. from 2017 to 2024, and Chief Business Officer at Celgene Cellular Therapeutics from 2013 to 2015.
He completed his undergraduate degree at Brown University and holds an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
JANUX THERAPEUTICS, INC.
0.00% | 2024-06-25 | 2,500 ( 0.00% ) | 133 750 $ | 2024-05-30 |
| 2024-04-09 | 10,600 ( 0.02% ) | 19 292 $ | 2024-05-30 |
Winston Kung active positions
| Companies | Position | Start |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Director/Board Member | 2022-09-21 |
| ARRIVENT BIOPHARMA, INC. | Director of Finance/CFO | 2023-12-31 |
Former positions of Winston Kung
| Companies | Position | End |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Director of Finance/CFO | 2024-01-03 |
Alliqua BioMedical, Inc.
 Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Director/Board Member | 2017-11-23 |
| CELGENE | Corporate Officer/Principal | 2017-10-31 |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Corporate Officer/Principal | 2015-01-31 |
| CITIGROUP INC. | Corporate Officer/Principal | 2013-03-31 |
Training of Winston Kung
| Brown University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| CITIGROUP INC. | Finance |
| PMV PHARMACEUTICALS, INC. | Commercial Services |
| JANUX THERAPEUTICS, INC. | Health Technology |
| ARRIVENT BIOPHARMA, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
Aitia, Inc.
 Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services GNS Healthcare, Inc. provides analytics solutions for the healthcare industry. The firm offers solutions for electronic health records, claims, clinical and incentive programs, reward, product development solutions for biopharmaceutical, diagnostic, consumer product, and medical device companies and publications, conference abstracts, and presentations. The company was founded by Colin Hill and Iya Khalil in 2000 and is headquartered in Cambridge, MA. | Commercial Services |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Health Technology |
| Alliance Management Group | |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Health Technology |
- Stock Market
- Insiders
- Winston Kung
